Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

Authors: Leach, A.J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, E.K., Santosham, M., Torzillo, P.J., McIntyre, P., Smith-Vaughan, H., Skull, S.A., Oguoma, V.M., Chatfield, M., Lehmann, D., Binks, M.J., Licciardi, P.V., Andrews, R., Snelling, T., Krause, V., Carapetis, J., Chang, A.B., Morris, P.S.

Source: In International Journal of Pediatric Otorhinolaryngology December 2023 175

Baseline incidence of adverse birth outcomes and infant influenza and pertussis hospitalisations prior to the introduction of influenza and pertussis vaccination in pregnancy : a data linkage study of 78 382 mother–infant pairs, Northern Territory, Australia, 1994–2015

Authors: McHugh, L., Andrews, R.M., Leckning, B., Snelling, T., Binks, M.J.

Source: Epidemiology and Infection, 2019 Jan 01. 147, 1-11.

Access URL: https://www.jstor.org/stable/27023565

A PCR-High-Resolution Melt Assay for Rapid Differentiation of Nontypeable Haemophilus influenzae and Haemophilus haemolyticus

Authors: Pickering, J., Binks, M.J., Beissbarth, J., Hare, K.M., Kirkham, L.-A.S., Smith-Vaughan, H.

Source: JOURNAL OF CLINICAL MICROBIOLOGY. 52(2):663-667

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN348580837&indx=1&recIds=ETOCRN348580837

Culture and PCR Detection of Haemophilus influenzae and Haemophilus haemolyticus in Australian Indigenous Children with Bronchiectasis

Authors: Hare, K.M., Binks, M.J., Grimwood, K., Chang, A.B., Leach, A.J., Smith-Vaughan, H.

Source: JOURNAL OF CLINICAL MICROBIOLOGY. 50(7):2444-2445

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN314611790&indx=1&recIds=ETOCRN314611790

Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial

Authors: Beissbarth, J.¹ (AUTHOR) Jemima.Beissbarth@menzies.edu.au, Wilson, N.¹ (AUTHOR), Arrowsmith, B.¹ (AUTHOR) Beth.Arrowsmith@telethonkids.org.au, Binks, M.J.¹ (AUTHOR) Michael.binks@menzies.edu.au, Oguoma, V.M.² (AUTHOR) victor.oguoma@menzies.edu.au, Lawrence, K.¹ (AUTHOR) Katrina.lawrence@menzies.edu.au, Llewellyn, A.¹ (AUTHOR) amy.bleakley@menzies.edu.au, Mulholland, E.K.^3,4 (AUTHOR) dKim.Mulholland@lshtm.ac.uk, Santosham, M.⁵ (AUTHOR) Msantosham@jhu.edu, Morris, P.S.^1,6 (AUTHOR) Peter.morris@menzies.edu.au, Smith-Vaughan, H.C.¹ (AUTHOR) Heidi.Smith-Vaughan@menzies.edu.au, Cheng, A.C.^7,8 (AUTHOR) allen.cheng@monash.edu, Leach, A.J.¹ (AUTHOR) amanda.leach@menzies.edu.au

Source: Vaccine. Apr2021, Vol. 39 Issue 16, p2264-2273. 10p.

Subject Terms: *STREPTOCOCCUS pneumoniae, *PNEUMOCOCCAL vaccines, *HAEMOPHILUS influenzae, *OTITIS media, *INDIGENOUS children, *TYMPANIC membrane perforation

Geographic Terms: AUSTRALIA